BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14659771)

  • 21. Risk of Post-TKA Acute Myocardial Infarction in Patients With a History of Myocardial Infarction or Coronary Stent.
    Kumar A; Tsai WC; Tan TS; Chiu LT; Kung PT; Lo CK; Ku MC
    Clin Orthop Relat Res; 2016 Feb; 474(2):479-86. PubMed ID: 26566978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone replacement therapy is associated with gastro-oesophageal reflux disease: a retrospective cohort study.
    Close H; Mason JM; Wilson D; Hungin AP
    BMC Gastroenterol; 2012 May; 12():56. PubMed ID: 22642788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
    Beral V; Bull D; Reeves G;
    Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women.
    Psaty BM; Heckbert SR; Atkins D; Lemaitre R; Koepsell TD; Wahl PW; Siscovick DS; Wagner EH
    Arch Intern Med; 1994 Jun; 154(12):1333-9. PubMed ID: 8002685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of hand osteoarthritis in new users of hormone replacement therapy: A nested case-control analysis.
    Burkard T; Rauch M; Spoendlin J; Prieto-Alhambra D; Jick SS; Meier CR
    Maturitas; 2020 Feb; 132():17-23. PubMed ID: 31883658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postmenopausal hormone use and risk of large-bowel cancer.
    Newcomb PA; Storer BE
    J Natl Cancer Inst; 1995 Jul; 87(14):1067-71. PubMed ID: 7616598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colon cancer risk and different HRT formulations: a case-control study.
    Dinger JC; Heinemann LA; Möhner S; Thai do M; Assmann A
    BMC Cancer; 2007 May; 7():76. PubMed ID: 17488513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone replacement therapy and secondary cardiovascular prevention: a meta-analysis of randomized trials.
    Cho L; Mukherjee D
    Cardiology; 2005; 104(3):143-7. PubMed ID: 16118493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women.
    Shlipak MG; Angeja BG; Go AS; Frederick PD; Canto JG; Grady D
    Circulation; 2001 Nov; 104(19):2300-4. PubMed ID: 11696469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years. Relationships to hormone replacement therapy.
    Lowe G; Woodward M; Vessey M; Rumley A; Gough P; Daly E
    Thromb Haemost; 2000 Apr; 83(4):530-5. PubMed ID: 10780311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of coronary heart disease in determining use of hormone replacement therapy in a general practice population.
    Chin BS; Futaba K; Jethwa A; Lip GY
    Int J Clin Pract; 2001 Oct; 55(8):515-8. PubMed ID: 11695070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormone replacement therapy and the risk of myocardial infarction in women with coronary risk factors.
    Petitti DB; Sidney S; Quesenberry CP
    Epidemiology; 2000 Sep; 11(5):603-6. PubMed ID: 10955415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency of family history of acute myocardial infarction in patients with acute myocardial infarction. Argentine FRICAS (Factores de Riesgo Coronario en America del Sur) Investigators.
    Ciruzzi M; Schargrodsky H; Rozlosnik J; Pramparo P; Delmonte H; Rudich V; Piskorz D; Negri E; Soifer S; La Vecchia C
    Am J Cardiol; 1997 Jul; 80(2):122-7. PubMed ID: 9230145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormone replacement therapy with estradiol and risk of venous thromboembolism--a population-based case-control study.
    Høibraaten E; Abdelnoor M; Sandset PM
    Thromb Haemost; 1999 Oct; 82(4):1218-21. PubMed ID: 10544901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tea consumption, incidence and long-term prognosis of a first acute myocardial infarction--the SHEEP study.
    Pyshchyta G; Mukamal KJ; Ahnve S; Hallqvist J; Gémes K; Ahlbom A; Janszky I
    Clin Nutr; 2012 Apr; 31(2):267-72. PubMed ID: 22075136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The management of menopause in women with a history of endometriosis: a systematic review.
    Gemmell LC; Webster KE; Kirtley S; Vincent K; Zondervan KT; Becker CM
    Hum Reprod Update; 2017 Jul; 23(4):481-500. PubMed ID: 28498913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormone replacement therapy and risk of non-fatal stroke.
    Pedersen AT; Lidegaard O; Kreiner S; Ottesen B
    Lancet; 1997 Nov; 350(9087):1277-83. PubMed ID: 9357407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased risk and worse prognosis of myocardial infarction in patients with prior hospitalization for epilepsy--the Stockholm Heart Epidemiology Program.
    Janszky I; Hallqvist J; Tomson T; Ahlbom A; Mukamal KJ; Ahnve S
    Brain; 2009 Oct; 132(Pt 10):2798-804. PubMed ID: 19717532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms in the platelet-specific collagen receptor GP6 are associated with risk of nonfatal myocardial infarction in Caucasians.
    Shaffer JR; Kammerer CM; Dorn J; Ferrell RE; Iacoviello L; Trevisan M; Donahue RP
    Nutr Metab Cardiovasc Dis; 2011 Aug; 21(8):546-52. PubMed ID: 20227257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.